126 related articles for article (PubMed ID: 2361757)
1. Classification of children as slow or rapid acetylators based on concentrations of isoniazid in saliva following oral administration of body-weight and surface-area-related dosages of the drug.
Sarma GR; Kailasam S; Datta M; Loganathan GK; Rahman F; Narayana AS
Indian Pediatr; 1990 Feb; 27(2):134-42. PubMed ID: 2361757
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid isoniazid concentrations in children with tuberculous meningitis: the influence of dosage and acetylation status.
Donald PR; Gent WL; Seifart HI; Lamprecht JH; Parkin DP
Pediatrics; 1992 Feb; 89(2):247-50. PubMed ID: 1734391
[TBL] [Abstract][Full Text] [Related]
3. Isoniazid acetylation phenotyping in Saudi Arabs.
Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
[TBL] [Abstract][Full Text] [Related]
4. Isoniazid acetylation metabolic ratio during maturation in children.
Pariente-Khayat A; Rey E; Gendrel D; Vauzelle-Kervroëdan F; Crémier O; d'Athis P; Badoual J; Olive G; Pons G
Clin Pharmacol Ther; 1997 Oct; 62(4):377-83. PubMed ID: 9357388
[TBL] [Abstract][Full Text] [Related]
5. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
Singh SP; Pande JN; Khilnani GC; Kailash S
Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
[TBL] [Abstract][Full Text] [Related]
6. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
Ellard GA
Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358
[TBL] [Abstract][Full Text] [Related]
7. [Acetylation phenotype in patients with cancer of the bladder. Preliminary report].
Skretowicz J; Polakowski P; Jeromin L; Zasada M; Szymańska J; Krajewska B
Med Pr; 1988; 39(4):241-5. PubMed ID: 3237058
[TBL] [Abstract][Full Text] [Related]
8. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
Dubbels R; Kattner E; Sell-Maurer D; Schloot W
Arzneimittelforschung; 1980; 30(9):1574-9. PubMed ID: 7193028
[TBL] [Abstract][Full Text] [Related]
9. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
Clark DW
Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
[TBL] [Abstract][Full Text] [Related]
10. Comparison between serum isonicotinic acid hydrazide (INH) levels and urinary sulfadimidine (sulfamethazine) acetylation as predictors of INH acetylator status.
Seth V; Seth SD; Beotra A; Singh U
Dev Pharmacol Ther; 1988; 11(1):32-6. PubMed ID: 3383719
[TBL] [Abstract][Full Text] [Related]
11. A new isoniazid preparation designed for moderately fast and "fast" metabolizers of the drug.
Eidus L; Hodgkin MM
Arzneimittelforschung; 1975 Jul; 25(7):1077-80. PubMed ID: 1101901
[TBL] [Abstract][Full Text] [Related]
12. [Antitubercular agents: pharmacogenetic factors in the development of adverse effects].
Ligueros M; Saavedra H; Neira S; Cruz-Coke R; Saavedra A; Kramer V; Gelman M; Nuñez A; Prieto JC
Rev Med Chil; 1990 Jul; 118(7):727-35. PubMed ID: 2131519
[TBL] [Abstract][Full Text] [Related]
13. [Isoniazid acetylation in a group of Tunisian patients. Report of 620 patients].
Mehiri BR; Zouaoui A; Chérif J; Ourari B; Daghfous R; Oueslati MH; Louzir B; Daghfous J; Chelbi B; Béji M
Tunis Med; 2005 Jul; 83(7):385-9. PubMed ID: 16220693
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
15. Incidence of isoniazid acetylation phenotypes in North Indians.
Gupta RC; Nair CR; Jindal SK; Malik SK
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):259-64. PubMed ID: 6746149
[TBL] [Abstract][Full Text] [Related]
16. The type of isoniazid acetylation in tuberculosis patients treated at National Tuberculosis and Lung Diseases Research Institute.
Augustynowicz-Kopeć E; Zwolska Z
Acta Pol Pharm; 2002; 59(6):443-7. PubMed ID: 12669768
[TBL] [Abstract][Full Text] [Related]
17. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
Ylitalo P; Auterinen L; Marttinen A; Koivula T
Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
[TBL] [Abstract][Full Text] [Related]
18. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases].
Bouayad Z; Chevalier B; Maurin R; Bartal M
Rev Fr Mal Respir; 1982; 10(6):401-7. PubMed ID: 7163595
[TBL] [Abstract][Full Text] [Related]
19. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains.
Hein DW; Smolen TN; Fox RR; Weber WW
J Pharmacol Exp Ther; 1982 Oct; 223(1):40-4. PubMed ID: 7120125
[TBL] [Abstract][Full Text] [Related]
20. Isoniazid acetylator phenotype.
Raghupati Sarma G
Indian Pediatr; 1989 Feb; 26(2):197-8. PubMed ID: 2753546
[No Abstract] [Full Text] [Related]
[Next] [New Search]
